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Abstract
Background: Interventions to reverse trends in malaria-related morbidity and mortality in Kenya focus on
preventive strategies and drug efficacy. However, the pattern of use of anti-malarials in malaria-endemic
populations, such as in western Kenya, is still poorly understood. It is critical to understand the patterns of anti-
malarial drug use to ascertain that the currently applied new combination therapy to malaria treatment, will
achieve sustained cure rates and protection against parasite resistance. Therefore, this cross-sectional study was
designed to determine the patterns of use of anti-malarial drugs in households (n = 397) in peri-urban location of
Manyatta-B sub-location in Kisumu in western Kenya.
Methods: Household factors, associated with the pattern of anti-malarials use, were evaluated. Using clusters,
questionnaire was administered to a particular household member who had the most recent malaria episode
(within <2 weeks) and used an anti-malarial for cure. Mothers/caretakers provided information for children aged
<13 years.
Results: Stratification of the type of anti-malarial drugs taken revealed that 37.0% used sulphadoxine/
pyrimethamine (SP), 32.0% artemisinin-based combined therapy (ACT), 11.1% anti-pyretics, 7.3% chloroquine (CQ),
7.1% quinine, 2.5% amodiaquine (AQ), while 3.0% used others which were perceived as anti-malarials (cough
syrups and antibiotics). In a regression model, it was demonstrated that age (P = 0.050), household size (P = 0.047),
household head (P = 0.049), household source of income (P = 0.015), monthly income (P = 0.020), duration of use
(P = 0.029), dosage of drugs taken (P = 0.036), and source of drugs (P = 0.005) significantly influenced anti-malarial
drug use. Overall, 38.8% of respondents used drugs as recommended by the Ministry of Health.
Conclusion: This study demonstrates that consumers require access to correct and comprehensible information
associated with use of drugs, including self-prescription. There is potential need by the Kenyan government to
improve malaria care and decrease malaria-related morbidity and mortality by increasing drug affordability,
ensuring that the recommended anti-malarial drugs are easily available in all government approved drug outlets
and educates the local shopkeepers on the symptoms and appropriate treatment of malaria. Following a switch to
ACT in national drug policy, education on awareness and behaviour change is recommended, since the efficacy of
ACT alone is not sufficient to reduce morbidity and mortality due to malaria.
Background
There has been some level of improper use of anti-
malarial drugs despite the fact that Plasmodium falci-
parum malaria still remains the primary cause of mor-
bidity and mortality amongst millions of people living in
Africa [1]. The lack of proper drug use has been pro-
moted largely over the years by the self-administration
of the most common anti-malarial drugs, particularly
chloroquine (CQ) [1]. In many situations, practices that
could best be described as misuse of drugs have become
routine, and in some cases, promoted institutionally [1].
This has further culminated into little interventions to
improve the use of anti-malarial drugs. Previously, both
CQ and sulphadoxine/pyrimethamine (SP) were
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tive to treat presumptive conditions of malaria rather
than to attempt to get microscopic confirmation, espe-
cially when this conventional method is unavailable, as
commonly experienced in most parts of Africa [1].
In particular, the pattern of anti-malarial drug use in
endemic areas of Africa is quite different from the pat-
tern of use of other drugs due to the high intensity of
malaria transmission in these areas. In areas of intense
malaria transmission, anti-malarial drugs are given
repeatedly to treat frequent fevers (even in the absence
of malaria) [2]. The practice of self-medication is also
increasingly becoming a major health concern. Research
finding shows that many illnesses including malaria, are
treated without consultations from health professionals
[3]. In areas where malaria transmission is endemic,
about 50-80% of people first visit private drug outlets
for malaria treatment and use these anti-malarial drugs
even without prescription, a practice which has resulted
in patterns such as over-use, under-use and irregular
use of these drugs [4].
Mortality in approximately 26,000 children and about
a third of out-patient attendance in health facilities
throughout Kenya annually is attributed to P. falci-
parum malaria. Adult disability due to malaria in this
region translates to an economic loss of about 160 mil-
lion working days per year [5]. The Kenyan National
Drug Policy was established in 1994 to check on medi-
cation, prescription and promotion of rational drug use.
However, the policy has never been meaningfully imple-
mented [5]. It is, therefore, critical to effectively evaluate
information on the drug use among the different popu-
lation. Further dissemination of these facts to both the
health authorities and the scientific communities will
facilitate effective understanding and help to address the
drug use patterns. The current study site, a peri-urban
location within Kisumu, is situated in a P. falciparum
holoendemic transmission area of western Kenya.
Malaria in this region accounts for 40% of out-patient
visits, and 40% of hospital in-patient admissions [6].
Malaria transmission occurs all year round, peaking in
the rainy season months of April and May [7]. Most
malaria cases in this region are managed at household
level. The patterns of use of anti-malarials include self-
prescription, sharing of drugs with friends and relatives
and premature discontinuation of treatment course [4].
Anti-malarials are usually bought from commercial
pharmacists, retail shops (e.g. grocery, general stores,
and community pharmacies) or from licensed and unli-
censed drug sellers. Most patients reporting at the
health facilities would have at least gone through home-
based treatment or local drug shops initially. Thus, seek-
ing health care from practitioners may be due mainly to
resistant, severe, or recurrent episodes [4]. Hence, there
is concern that household and communities’ patterns of
use of anti-malarial drugs are often inadequate and
inappropriate depending on the practices adopted for
use of medicines not only for malaria [8]. The situation
may be worse among households living in malaria ende-
mic regions such as western Kenya, since high endemi-
city may mean that the population invents mechanisms
for surviving constant malarial episodes rather than seek
adequate healthcare. It is therefore imperative to under-
stand how anti-malarial drugs are used in such areas. In
addition, since few documented studies have been car-
ried out to link household factors such as economic
level coupled with high endemicity, with the patterns of
use of anti-malarials, it is upon this background that we
report on the factors determining the patterns of anti-
malarial drugs use among the residents of a peri-urban
region of Kisumu in Western Kenya.
Methods
Study setting
The current study was carried out in Manyatta-B sub-
location in Winam division of Kisumu. The area consists
of three villages, Lower Kanyakwar, Upper Kanyakwar
and Kuoyo, which are further divided into nine smaller
units depending on the sub-clan boundaries. Within the
sub-clan boundaries are informal dwellings within and
outside some of the homesteads. According to the last
population census, the total number of inhabitants in this
sub-location is 21,027 in 6,035 households [9]. The total
area is 3.3 km
2 with a density of 6, 372 people/km
2 [9].
Housings consist of mostly rented rooms within an area
of 10-20 m
2 for 4-8 persons in a household. These indivi-
duals live in a congested and miserable conditions, with
considerable lack of the basic necessities of life, such as
clean piped-water and proper housing conditions [10].
The density of the population and the closely-packed
housing conditions contributes to poor drainage; hence,
stagnant water, which form good breeding grounds all
year round for malaria vectors [11].
Study participants
In order to determine the patterns of use of anti-malar-
ial drugs in the study population at a point in time, resi-
dents living within households (n = 397) in the above
described peri-urban region of Kisumu in western
Kenya, were recruited. This was a descriptive cross-sec-
tional survey in which sampling was carried out using
cluster method as previously described [12]. A total of
6,035 households in nine clusters were sampled in order
to achieve the required sample size. Data was collected
through interviews, using structured questions in
selected households in which diagnosed or self-reported
episodes of malaria occurred within the last two weeks
prior to the interview dates.
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above described households and who had experienced
malaria and used anti-malarial or other drugs perceived
by them as anti-malarial, due to self/presumptive or
laboratory diagnosis within the previous two weeks. In
the absence of laboratory diagnosis, malaria according
to residents in the study area was defined by either the
presence or mixed symptoms of fever, diarrhoea, vomit-
ing and pain in the joints. However, if more than one
individual in a household had experienced malaria and
had used anti-malarial or other drugs viewed or per-
ceived by them as an anti-malarial within the described
period (i.e. two weeks), then focus was on the most cur-
rent episode, while the rest were excluded. This strategy
was adopted so as to capture the most recent pattern of
anti-malarial drug use and to minimize errors associated
with recall. If no one had experienced malaria episodes
within the previous two weeks, the interviewer moved
to the next household in the cluster. Correct drug use
was assessed by questionnaires through identification of
the drug used and whether or not the respondents used
it as per the prescription. The study was approved by
the ethical and scientific review committees at the
Kenya Medical Research Institute and the Great Lakes
University of Kisumu Ethical Review Board (GERB),
Kenya.
Sampling design
This study employed cluster sampling method in select-
ing the households in the study area. A total of nine
clan regions were chosen as clusters. The study units
comprised households within the cluster that had its
member experiencing malaria in the last two weeks. The
probability of selection of the primary sampling units
for each cluster was proportional to the estimated sam-
ple size. From each cluster, households were then
selected on continuous basis until the total number (n =
397) required was achieved.
Research procedure
The quantitative data, which was collected from 397
households was performed through interviews using
structured questions. The tool of data collection was a
pre-prepared questionnaire, which was administered to
the particular household member, who had previous
malaria episode and used anti-malarial or drug perceived
to be an anti-malarial. However, in cases of children
below the age of 13 years, mothers or caretakers pro-
vided the information. Using clusters, households with
malaria episodes were established first through identifi-
cation interview, which involved all the households
starting with exactly the first household visited in the
cluster. The interview was then repeated in all the
households identified until the required number was
achieved. As stated above, particular emphasis was on
the most recent episode of self/presumptive or labora-
tory diagnosed malaria in the household. Research/field
assistants (n = 5) who were involved in data collection,
used drug charts containing samples of commonly used
anti-malarial drugs to aid in recall and to validate
reports. In addition, remaining packages or tablets were
reviewed where possible.
Prior to the actual study, the field assistants’ who were
themselves residents of the study sub-location and with
a minimum of form four level of education, were inter-
viewed and recruited as enumerators. They were
required to be fluent in English, Swahili and DhoLuo
languages. Training of the research assistants on survey
interviewing techniques was carried out for one day fol-
lowed by a second day of pre-testing of survey tools and
methodologies in a neighbouring community with the
same characteristics. Based on the experiences and
results of the pre-test, further re-training and refining of
techniques of interviewing and modification of research
tool was performed.
Statistical analyses
Statistical analyses were performed using SPSS (Version
15.0). Logistic regression analysis between the indepen-
dent and dependant variables was used to identify vari-
ables associated with pattern of use of anti-malarial
drugs. The variables included in the logistic regression
model included; demographic (age, gender, marital sta-
tus, household head, and household size); socio-eco-
nomic (household breadwinner, source of income,
household monthly income, education level and ability to
read) and environmental (source of drugs, distance to
source of drugs, and availability of anti-malarial drug at
source) factors. The variables that were significantly asso-
ciated with pattern of use (drugs taken, duration, dosage
and source of drugs) were further analyzed using Chi-
square tests. Proportions on knowledge, drug-taking
behaviour and correctness of patterns of use were deter-
mined. A P ≤ 0.05 was considered statistically significant.
Results
Demographic characteristics of the study participants
A total of 397 households were included in the analyses
to determine factors associated with anti-malarial drugs
use patterns. Overall, males were 183 (46.1%) while
females were 214 (53.9%) (Table 1). In terms of age,
those who were aged <13 years were 262 (66.0%) while
135 (34.0%) were ≥13 years. The distribution of indivi-
duals per household were as follows; 1-2 individuals [81
(20.4%)], 3-5 individuals [215 (52.4%)], and ≥6 indivi-
duals [101 (25.4%)]. Households headed by husbands
were 267 (67.3%); wives 76 (19.1%) and caretakers 51
(12.8%), while 3 (0.8%) were headed by others.
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23 (5.8%) and widowed 12 (3.0%) while underage indivi-
duals (i.e. below 15 years and not marriageable) were
271 (68.4%).
Levels of education varied in that approximately 13.4%
had achieved primary education, 12.1% secondary edu-
cation, 2.5% had post-secondary education, while 14.1%
were still in school. In addition, 3.0% did not have any
form of education while 54.9% were underage children
(i.e. <6 years and not started any formal education). The
primary breadwinners for most households were hus-
bands (69.9%), wives (15.9%) and others (14.2%). Self-
employment (37.9%) was the main source of income
while petty business (25.5%), salary (20.2%), casual work
(15.4%), and farming and the other sources of income
were (1%). The respondents with monthly income of
below KShs. 4,500 were 41.2%, between KShs. 4,500-
9,000 were 46.5%, while over KShs. 9,000 were 12.4%. A
total of 79.8% and 20.2% of respondents were able and
unable to read prescriptions, respectively (Table 1).
In terms of drug use, further findings revealed that
most respondents used SP and ACT relative to other
drugs, with close variations in their use. In addition,
more than half of the respondents took the drugs within
the correct duration in each case considered, except for
households who were headed by wives (46.1%). Further-
more, majority in the different categories used the cor-
rect dose as opposed to lower proportions of individuals
who used the incorrect dose (Table 1).
Sources of anti-malarials in the peri-urban population
In order to determine whether the drugs were acquired
from the correct sources with the right prescriptions,
respondents were asked about the sources of their
drugs. Results indicated that a total of 30.5% of drugs
were from government institutions, 30.3% from nearby
shops, 18.3% from pharmacies/chemists, 16.4% from pri-
vate clinics, 1.0% from street vendors, 1.5% from
friends/neighbours/relatives, and 2.0% were left-over
drugs in the households.
Since the source can determine the type of drug used,
the study further assessed the pattern of individual drug
used from the above sources. For quinine, the main
source was government health institutions (66.4%) and
p r i v a t ec l i n i c s( 3 3 . 6 % ) .T h eA C Td r u g sw e r em a i n l y
sourced from government health institutions (60.0%),
pharmacy/chemists (25.2%) and private clinics (14.8%).
The main source of SP drugs was shops/kiosks (70%)
while pharmacy/chemists (21.2%) and private clinics
(8.8%). Other sources of anti-malarials included street
vendors, friends/relatives/neighbours and left-over medi-
cine in the households whose proportions were <20%
for each of the categories.
Distance to the source of an anti-malarial drug was
measured by the time taken to reach the source while
walking. Respondents who took less than 30 minutes
were 57.4% while 42.6% took more than 30 minutes to
reach the source of drug. Furthermore, 48.0% of respon-
dents accessed the anti-malarial drugs at the respective
Table 1 Demographic characteristics and the use of three major anti-malarial drugs
Demographic factors Drugs taken Duration of use Dosage of use
SP ACT Quinine Correct Incorrect Correct Incorrect
Age <13 years 98 (37.4%) 86 (32.8%) 20 (7.6%) 159 (60.7%) 103 (39.3%) 202 (77.1%) 60 (22.9%)
≥13 years 49 (36.3%) 41 (30.4%) 8 (5.9%) 69 (51.1%) 51 (48.9%) 102 (75.6%) 33 (24.4%)
Gender Male 67 (36.6%) 60 (32.8) 16 (8.7%) 104 (56.8%) 79 (43.2%) 146 (79.8%) 37 (20.2%)
Female 80 (37.4%) 67 (31.3%) 12 (5.6%) 124 (57.9%) 90 (42.1%) 158 (73.8%) 56 (26.2%)
Marital status Single 7 (30.4%) 6 (26.1%) 2 (8.7%) 14 (60.9%) 9 (39.1%) 18 (78.3%) 5 (21.7%)
Married 31 (31.2%) 31 (35.2%) 3 (3.4%) 50 (56.8%) 38 (43.2%) 67 (76.1%) 21 (23.9%)
Separated 1 (50.0%) 0 0 0 (0.00%) 2 (100%) 1 (50.0%) 1 (50.0%)
Widowed 5 (41.7%) 0 3 (25.0%) 8 (66.7%) 4 (33.3%) 8 (66.7%) 4 (33.3%)
Underage 102 (37.6%) 90 (33.2%) 20 (7.4%) 155 (57.3%) 116 (42.8%) 209 (77.1%) 62 (22.9%)
HH head Husband 108 (40.4%) 88 (33.0%) 13(4.9%) 161 (60.3%) 106 (39.7%) 205 (76.8%) 62 (23.2%)
Wife 24 (31.6%) 25 (32.9%) 9 (11.8%) 35 (46.1%) 41 (53.9%) 58 (76.3%) 18 (23.7%)
Caretaker 14 (27.5%) 13 (25.5%) 6 (11.8%) 30 (58.8%) 21 (41.2%) 39 (76.5%) 12 (23.5%)
Others 1 (33.3%) 1 (33.3%) 0 1 (33.3%) 2 (66.7%) 2 (66.7%) 1 (33.3%)
HH size 1-2 32 (39.5%) 27 (33.3%) 4 (4.9%) 42 (51.9%) 39 (48.1%) 59 (72.8%) 22 (27.2%)
3-5 83 (38.6%) 65 (30.2%) 16 (7.4%) 127 (59.1%) 88 (40.9%) 167 (77.7%) 48 (22.3%)
6 and above 32 (31.7%) 35 (34.7%) 8 (7.9%) 59 (58.4%) 42 (41.6%) 78 (77.2%) 23 (22.8%)
HH- Household, SP- Sulphadoxine pyremethamine, ACT- Artemether-based combined therapies. Proportionality determined by Chi-square test. From the Table,
most respondents used SP and ACT relative to other drugs, with close variations in their use. In addition, more than half of the respondents took the drugs
within the correct duration in each case considered, except for households who were headed by wives (46.1%). Furthermore, majority in the different categories
used the correct dose as opposed to lower proportions of individuals who used the incorrect dose.
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t h a tw e r ea v a i l a b l ea n dt h es o u r c ew a sas h o r t e rd i s -
tance to the respondent (Table 2).
Association between demographic, socio-economic, and
environmental factors and anti-malarial drug use patterns
In order to determine factors influencing patterns of use
of anti-malarial drugs in the peri-urban population, a
logistic regression analysis was performed. The indepen-
dent variables included demographic (age, gender, mari-
tal status, household head, and household size), socio-
economic (household breadwinner, source of income,
household monthly income, education level and ability
to read) and environmental factors (source of drugs, dis-
tance to source of drugs, and availability at source). The
above factors were regressed against the outcome vari-
ables (i.e. drugs taken, duration of use and dosage/fre-
quency of use). Age was a significant factor in
determining duration of anti-malarial use since many
r e s p o n d e n t s( 6 0 . 7 % )w h ow e r e< 1 3y e a r st o o kd r u g sf o r
correct duration as opposed to respondents who were
≥13 years (39.3%) (b = 0.179, P = 0.050). The household
head determined duration of use since 60.3% of house-
holds headed by husbands took anti-malarial drugs for
the correct duration as compared to other household
headed by either wives or any other person other than
husbands (b = 0.093, P = 0.047%). In addition, house-
hold size significantly influenced the types of anti-malar-
ial drugs used (b = 0.092, P = 0.049) (Table 3). A higher
proportion of the respondents whose household sizes
were 3-5 (68.9%) or ≥6 (20.1%) used SP as compared to
households with 1-2 individuals (11.0%) (P =0 . 0 1 5 ) .
Furthermore, household source of income significantly
influenced duration for use (b =0 . 0 9 7 ,P =0 . 0 5 0 )s i n c e
a higher proportion of respondents who were salaried
(21.9%) or self-employed (38.6%) used drugs within the
specified duration relative to those with other sources of
income (P = 0.017). In addition, household monthly
income significantly influenced dosage of the drugs used
(b = 0.113, P = 0.034) (Table 3), primarily due to the
fact that higher proportions of respondents with an
income salary of KShs. 4500-9000 (48.5%) took the cor-
rect dosage of drugs as opposed to individuals with
other incomes (P = 0.020).
Additional analyses revealed that the source of drugs
significantly predicted pattern of anti-malarial drug use
by determining dosage (b =0 . 0 1 3 ,P =0 . 0 0 5 )a n dd r u g
taken (b = 0.113, P =0 . 0 3 6 ) .T h i so b s e r v a t i o ni si nl i n e
with the fact that higher proportions of respondents
who took the correct dosage of drug either acquired
Table 2 Socio-economic factors and the use of three major anti-malarial drugs
Socio-economic factors Drugs taken Duration of use Dosage of use
SP ACT Quinine Correct Incorrect Correct Incorrect
Education level Primary 19 (35.8%) 18 (34.0%) 5 (9.4%) 28 (52.8%) 25 (47.2%) 44 (83.0%) 9 (17.0%)
Secondary 19 (39.6%) 15 (31.3%) 1 (2.1%) 5 (50.0%) 21 (43.8%) 36 (75.0%) 12 (25.0%)
Post-Secondary 5 (50.0%) 3 (30.0%) 0 27 (56.3%) 5 (50.0%) 6 (60%) 4 (40.0%)
Still in school 17 (30.4%) 20 (35.7%) 4 (7.1%) 37 (66.1%) 19 (33.9%) 45 (80.4%) 11(19.6%)
None 4 (33.3%) 0 1 (8.3%) 10 (83.3%) 2 (16.7%) 8 (66.7%) 4(33.3%)
Under 6 83 (38.1%) 71 (32.6%) 17(7.8%) 121 (55.5%) 97 (44.5%) 165 (75.7%) 53(24.3%)
HH breadwinner Husband 105 (37.9%) 97 (35.0%) 16 (5.8%) 164 (59.2%) 113 (40.8%) 219 (79.1%) 58 (20.9%)
Wife 21 (33.3%) 18 (28.6%) 4 (6.3%) 30 (47.6%) 33 (52.4%) 45 (71.4%) 18 (28.6%)
Others 21 (37.3%) 11 (20.4%) 8 (14.8%) 34 (61.1%) 22 (38.9%) 39 (68.5%) 17 (31.5%)
HH inc. source Salaried 27 (33.8%) 29 (36.3%) 6 (7.5%) 50 (62.5%) 30 (37.5%) 65 (81.3%) 15 (18.8%)
Self employed 53 (35.3%) 47 (31.3%) 7 (4.7%) 96 (64.0%) 54 (36.0%) 110 (73.3%) 40 (26.7%)
Petty business 42 (41.6%) 27(26.7%) 11 (10.9%) 51 (50.5%) 50 (49.5%) 79 (78.2%) 22 (21.8%)
Casual worker 24 (39.3%) 23 (37.7%) 4 (6.6%) 29 (47.5%) 32 (52.5%) 47 (77.0%) 14 (23.0%)
Farming 1 (50.0%) 1 (50.0%) 0 1 (50.0%) 1 (50.0%) 1(50.0%) 1 (50.0%)
Others 0 0 0 1(50.0%) 1 (50.0%) 1 (50.0%) 1 (50.0%)
HH monthly inc. Below Ksh.4500 56 (34.4%) 48 (29.4%) 11 (6.7%) 85 (52.1%) 78 (47.9%) 115 (70.6%) 48 (29.4%)
Ksh.4500-9000 74 (40.2%) 58 (31.5%) 12 (6.5%) 111 (60.3%) 73(39.7%) 147 (79.9%) 37 (20.1%)
Over Ksh. 9000 17 (35.4%) 21 (43.8%) 4(8.3%) 30 (62.5%) 18 (37.5%) 40 (83.3%) 8 (16.7%)
Ability to read Able to read 121 (38.2%) 114 (36.0%) 20 (6.3%) 181 (57.1%) 136 (42.9%) 246 (77.6%) 71 (22.4%)
Unable to read 26 (32.9%) 13 (16.5%) 7 (8.9%) 46 (58.2%) 33 (41.8%) 57 (72.2%) 22 (27.8%)
Data are presented as proportions (n,%). HH-Household, SP- Sulfadoxine pyremethamine, ACT- Artemether-based combined therapies, inc.-Income. From the
results above the drugs that were taken by majority of the respondents were SP and ACT in all the socio-economic factors considered, with very small
differences in proportions in each category. In addition, averagely half of the households had used drugs for correct duration, unlike households whose
breadwinners were wives (47.6%) and those who depended on casual work as the main source of income (47.5%). Moreover, most households took correct
dosages of drugs with majority scoring more than 70% in each socio-economic factor considered.
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macy/chemists (24%) relative to other sources (P =
0.004). Moreover, availability at source significantly
influenced anti-malarial drug taken (b = 0.092, P =
0.046) (Table 3). Taken together, these results demon-
strate that in this peri-urban population of Kisumu, age,
household head, household size, source of income, level
of monthly income, the source of anti-malarial and
availability at the source significantly influence pattern
of anti-malarial use.
Discussion
The importance of understanding how anti-malarial
drugs are used in a community and consequently how
their use might be improved draws a considerable inter-
est and concern in translating anti-malarial efficacy into
effectiveness in various settings in malaria-affected com-
munities. This study was designed to investigate the
demographic, socio-economic and environmental factors
that influence anti-malarial drug use in a peri-urban
region within Kisumu in western Kenya. The findings
presented here demonstrate that age, household head,
household size, source of income, level of monthly
income, the source of anti-malarial and availability at
the source significantly influence pattern of anti-malarial
use.
Age influenced pattern of anti-malarial use by influen-
cing duration for use. A total of 60.7% individuals <13
years used drugs for correct duration while only 51.1%
≥13 years of age used drugs for correct duration. Higher
proportion of individuals (i.e. children) <13 years taking
drugs for correct duration may be attributed to the fact
that they are dependent on caretakers in making health
decisions and supervisions. Further analyses demon-
strated that gender and marital status did not influence
the pattern of anti-malarial use. This finding is consis-
tent with a previous study carried out in Turkey to
determine knowledge on malaria and behaviour in ende-
mic rural area in which there were no relationships
between adherence and race, gender and marital status
[13]. However, the current findings and the previous
ones [13] are inconsistent with a study carried out in
Sudan among college students on self-medication prac-
tices with antibiotics and anti-malarial drugs [14] and in
a community-based cross-sectional survey in Tulu Dis-
trict in southern-central Ethiopia [15], in which it was
demonstrated that treatment-seeking behavior for
malaria was not affected by age.
Household head influenced the pattern of use of anti-
malarial drugs by influencing the duration for use. This
observation could be attributed to the fact that hus-
bands, being majority of the household heads were also
the primary breadwinners, and hence, were influencing
health decisions in the household. In addition, the
household size influenced patterns of use of anti-malar-
ial drugs since it determined the anti-malarial drugs
taken in the household. Households with 1-2 individuals
had a tendency to take the correct dosage within the
correct duration relative to households with three or
more individuals, which demonstrated an irregular
Table 3 Demographic, socio-economic and environmental factors associated with patterns of use of anti-malarial
drugs
Dependent variables
Drugs taken Dosage of use Duration of use
Independent variables
Age (A) b = 0.113, P = 0.230 b = 0.006, P = 0.949 b = 0.179, P = 0.050
Gender (G) b = 0.008, P = 0.872 b = 0.061, P = 0.235 b = 0.018, P = 0.722
Marital status (MS) b = 0.101, P = 0.341 b = 0.115, P = 0.279 b = 0.105, P = 0.322
Household size (HHS) b = 0.092, P = 0.049 b = 0.027, P = 0.606 b = 0.008, P = 0.873
Household head (HHH) b = 0.019, P = 0.726 b = 0.011, P = 0.841 b = 0.093, P = 0.047
Education level (EL) b = 0.018, P = 0.828 b = 0.132, P = 0.104 b = 0.057, P = 0.486
Household breadwinner (HHB) b = 0.008, P = 0.883 b = 0.086, P = 0.113 b = 0.071, P = 0.188
Household income source (HIS) b = 0.028, P = 0.597 b = 0.010, P = 0.846 b = 0.097, P = 0.050
Household monthly income (HHI) b = 0.037, P = 0.486 b = 0.113, P = 0.034 b = 0.064, P = 0.233
Ability to read (AR) b = 0.059, P = 0.268 b = 0.005, P = 0.926 b = 0.030, P = 0.570
Source of drug (SD) b = 0.113, P = 0.036 b = 0.013,P = 0.005 b = 0.029, P = 0.596
Distance to source (DS) b = 0.049, P = 0.373 b = 0.021, P = 698 b = 0.058, P = 0.293
Availability at source (AS) b = 0.092, P = 0.046 b = 0.002, P = 965 b = 0.060, P = 0.252
Logistic regression analysis between the independent and dependant variables was used to identify variables associated with pattern of use of anti-malarial
drugs, including demographic, socio-economic and environmental factors. P-values in bold were statistically significant at P ≤ 0.05. b = standard co-efficient. The
result above shows that age, household size, source of drugs and availability of drugs at the source work together to influence types of anti-malarial that are
taken in the households. Furthermore, household monthly income and source of drug work together to influence dosage of use; while age, household head and
household income source work together to influence duration of use of these drugs.
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household sizes, due to economic strain, need more
finances to maintain, hence would prefer cheaper anti-
malarials, which then affects the type, dosage and dura-
tion of use.
Assessment of socio-economic factors that could influ-
ence anti-malarial drug use revealed that households
with a monthly income of KShs. 9000 took correct
dosages as opposed to those with other incomes.
Furthermore, most households which depended on sal-
ary and on self-employment took drugs for correct
duration as opposed to households with other sources
of income. These results are comparable to a study in
Uganda [16] and Ethiopia [17], which were designed to
determine healthcare-seeking behaviour for malaria
treatment in which higher income households frequently
obtained their drugs from commercial drug stores
because they could afford them. In line with this argu-
ment, higher income households in the current study
were also able to afford the drugs and hence use correct
doses.
Assessment of environmental factors that can influ-
ence anti-malarial drug use revealed that the source of
drugs and availability at source influenced pattern of use
by influencing dosage and drugs taken, respectively.
This observation was mainly because higher proportions
of the respondents who took the correct dosage of drug
either acquired the drugs from government health facil-
ities or from pharmacy/chemists as opposed to other
sources. In addition, availability of drugs determined
which drugs are obtainable for use. These findings are
consistent with findings in a study carried out in South-
ern Ethiopia on self-treatment of malaria in rural com-
munities, where it was demonstrated that anti-malarial
drugs were bought from markets or any shops because
it was close to home (43.6%), the drugs were available
(25.8%), the shops were easily accessible (20.9%), and
waiting time was short (11.5%) [17]. In a different study
in Kenya, it has been demonstrated that utilization of
health facilities decreased slightly with increasing dis-
tance of participants’ place of residence to health facil-
ities for up to 6 km [18]. In line with these previous
observations, findings in this study indicate that large
segment of the households in the peri-urban population
are living within a short radius from health facilities, or
alternative sources of anti-malarial drugs. Consequently,
it is reasonable to suggest that this may produce a level-
ling effect and may not be an influencing factor in pat-
tern of use of anti-malarial. In terms of source of drugs,
most respondents in the current study obtained their
anti-malarial drugs from government health facilities,
contrary to previous studies in other similar P. falci-
parum endemic regions in which anti-malarial drugs
were obtained from local shops [19,20]. However, the
f i n d i n g sf r o mt h ec u r r e n ts t u d yc o n c u r sw i t ht h eb e h a -
vioural patterns observed in a study in Kipsamoite area,
which is a highland region of Kenya (with unstable
malaria transmission pattern) in which medical facilities
were the most common initial treatment source for
both adults (66.0%) and children (66.7%). Local shops
were the most popular alternative, providing initial
treatment for 19.0% of adults and 30.3% of children
[21]. The observed patterns in the current study could
be due to improved availability and provision of subsi-
dized anti-malarial drugs at government facilities. It is
important to note that even though local shops were
not the most popular source of anti-malaria drugs in
the current setting, they were the most frequently
sought source after government medical facilities. As a
result, a significant portion of the population received
anti-malarial drugs for perceived malaria from the local
shops. These findings indicate that, despite increased
reliance on government facilities in this peri-urban area,
local shops are an important source of anti-malarial
drugs and should be considered when designing treat-
ment and intervention programmes.
Conclusion
In conclusion, there is potential need by the Kenyan
government to improve malaria care and decrease the
malaria-related morbidity and mortality by increasing
drug affordability, ensuring that the recommended anti-
malarial drugs are easily available in all government
approved drug outlets and in addition, educate the local
shopkeepers on the symptoms and appropriate treat-
ment of malaria. Additional efforts should be made in
further organizing awareness campaigns to educate the
locals on the clinical symptoms of malaria. Such educa-
tional interventions have been shown to change malaria
treatment-seeking behaviour in other malaria endemic
areas [22-24].
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